KCFA
Key Client Fiduciary Advisors’s Cytosorbents Corp CTSO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $100K | Hold |
78,457
| – | – | 0.04% | 200 |
|
|
2025
Q1 | $78.5K | Buy |
78,457
+43,900
| +127% | +$43.9K | 0.04% | 184 |
|
|
2024
Q4 | $31.4K | Hold |
34,557
| – | – | 0.01% | 189 |
|
|
2024
Q3 | $51.8K | Hold |
34,557
| – | – | 0.02% | 194 |
|
|
2024
Q2 | $24.3K | Hold |
34,557
| – | – | 0.01% | 184 |
|
|
2024
Q1 | $32.8K | Buy |
34,557
+22,557
| +188% | +$21.4K | 0.02% | 182 |
|
|
2023
Q4 | $13.3K | Sell |
12,000
-1,000
| -8% | -$1.11K | 0.01% | 169 |
|
|
2023
Q3 | $24.4K | Buy |
13,000
+1,000
| +8% | +$1.88K | 0.02% | 167 |
|
|
2023
Q2 | $43.1K | Hold |
12,000
| – | – | 0.03% | 172 |
|
|
2023
Q1 | $40.4K | Hold |
12,000
| – | – | 0.03% | 164 |
|
|
2022
Q4 | $18.6K | Hold |
12,000
| – | – | 0.01% | 154 |
|
|
2022
Q3 | $16K | Hold |
12,000
| – | – | 0.01% | 104 |
|
|
2022
Q2 | $26K | Buy |
+12,000
| New | +$26K | 0.03% | 108 |
|